Next Sequence (founded in 2021) is an accelerator‐style venture capital firm that invests in and supports TechBio / synthetic biology start-ups worldwide. Head-quartered in New York, the firm runs 6- to 12-month programs, providing capital and hands-on help to companies that merge artificial intelligence with biology.
Focus Areas
Notable Investments
